CVE-2026-32036 Details
Description
OpenClaw gateway plugin versions prior to 2026.2.26 contain a path traversal vulnerability that allows remote attackers to bypass route authentication checks by manipulating /api/channels paths with encoded dot-segment traversal sequences. Attackers can craft alternate paths using encoded traversal patterns to access protected plugin channel routes when handlers normalize the incoming path, circumventing security controls.
A path traversal vulnerability has been identified in OpenClaw gateway plugin versions prior to 2026.2.26. This vulnerability allows remote attackers to bypass authentication checks on protected plugin channel routes by manipulating the /api/channels paths with encoded dot-segment traversal sequences. When plugin handlers normalize the incoming paths, the encoded traversal patterns can be used to access routes that should be protected, effectively circumventing security controls.
Users can upgrade to OpenClaw gateway plugin version 2026.2.26 or later to address this vulnerability.
Metrics
CVSS 4.0 Severity and Vector Strings:
CVSS 3.x Severity and Vector Strings:
No data available for CVSS Version 2.0 on this CVE.
CISA-ADP
Assessed Mar 20, 2026References to Advisories, Solutions, and Tools
By selecting these links, you will be leaving this site. These are references gathered from the official CVE record and are not endorsed by Volerion.
Weakness Enumeration
| CWE-ID | CWE Name | Source |
|---|---|---|
| CWE-22 | Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') | [email protected] |
| CWE-289 | Authentication Bypass by Alternate Name | [email protected] |
Affected Products
| Product | Versions |
|---|---|
| openclaw openclaw | < 2026.2.6 |
CPE
Remediation
| |
Change History
4 change records found show changes
| Date | Action | Recorded By |
|---|---|---|
| Jun 17, 2026 | CVE Modified | [email protected] |
| Jun 17, 2026 | CVE Modified | CISA-ADP |
| Mar 23, 2026 | Initial Analysis | [email protected] |
| Mar 19, 2026 | New CVE Received | [email protected] |